|
2023
|
Invention
|
Methotrexate treatment methods.
The present disclosure provides compositions of methotrexate for... |
|
|
Invention
|
Methotrexate treatment methods. The present disclosure provides compositions of methotrexate for ... |
|
|
Invention
|
Deuterated compounds and uses thereof.
The present invention provides for the treatment, prevent... |
|
|
Invention
|
Modified cyclodextrins and ophthalmic uses thereof. The present invention provides for the treatm... |
|
|
Invention
|
Ophthalmic formulations and uses thereof.
The present invention provides a reproxalap ophthalmic... |
|
|
Invention
|
Compositions and methods for the treatment of macular degeneration. The present invention is dire... |
|
|
Invention
|
Toxic aldehyde related diseases and treatment. The present invention provides for the treatment, ... |
|
|
P/S
|
pharmaceuticals in the nature of eye drops for the treatment of dry eye disease and allergic conj... |
|
|
Invention
|
Compositions and methods of treating retinal disease.
Compositions and methods for treating macu... |
|
|
Invention
|
Treatment of inflammatory disorders.
The present disclosure provides compounds and methods of us... |
|
|
Invention
|
Methods of treating sjögren-larssen syndrome. The present invention relates to methods of treatme... |
|
2022
|
P/S
|
pharmaceuticals in the nature of an injectable solution for intravitreal use for the prevention ... |
|
|
Invention
|
Ophthalmic formulations of methotrexate. The present disclosure provides formulations of methotre... |
|
|
Invention
|
Deuterated compounds and uses thereof. The present invention provides for the treatment, preventi... |
|
|
Invention
|
Heterocyclic aldehyde trapping compounds and uses thereof.
The present invention provides for th... |
|
|
Invention
|
Heterocyclic aldehyde trapping compounds and uses thereof. The present invention provides for the... |
|
|
Invention
|
Treatment of dry eye disease.
The present invention provides a reproxalap ophthalmic solution, a... |
|
|
Invention
|
Treatment of dry eye disease. The present invention provides a reproxalap ophthalmic solution, an... |
|
2021
|
Invention
|
Formulations for treatment of dry eye disease.
The present invention provides a reproxalap ophth... |
|
|
Invention
|
Combination treatment of ocular inflammatory disorders and diseases.
The present disclosure prov... |
|
|
Invention
|
Polymorphic compounds and uses thereof. The present invention provides freebase and salt forms, a... |
|
|
Invention
|
Dry eye disease biomarkers and their use for treatment.
The present invention relates to use of ... |
|
|
Invention
|
Dry eye disease biomarkers and their use for treatment. The present invention relates to use of b... |
|
|
Invention
|
Pharmaceutical formulations and uses thereof. The present invention relates to pharmaceutical com... |
|
|
Invention
|
Polymorphic compounds and uses thereof. The present invention relates to free-base and salt forms... |
|
|
Invention
|
Treatment of inflammatory disorders. The present disclosure provides compounds and methods of use... |
|
|
Invention
|
Quinoline compounds for treating lung, liver, and kidney diseases, disorders, or conditions.
The... |
|
|
Invention
|
Aldehyde conjugates and uses thereof.
The present invention provides compounds and methods of us... |
|
|
Invention
|
Quinoline compounds for treating lung, liver, and kidney diseases, disorders, or conditions. The ... |
|
|
Invention
|
Quinoline compounds for treating respiratory disorders and viral infections.
The present inventi... |
|
|
Invention
|
Quinoline compounds for treating respiratory disorders and viral infections. The present inventio... |
|
|
Invention
|
Compositions and methods of treating retinal disease. Compositions and methods for treating macul... |
|
2020
|
Invention
|
Ophthalmic formulations of methotrexate.
The present disclosure provides formulations of methotr... |
|
|
Invention
|
Process for preparation of aldehyde scavenger and intermediates. The present invention relates to... |
|
2019
|
Invention
|
Injectable formulations.
The present disclosure relates to therapeutic compounds and formulation... |
|
|
Invention
|
Contact lens solutions and kits.
The present disclosure relates to contact lens solution compris... |
|
|
P/S
|
Pharmaceutical agents for Reactive Aldehyde Species (RASP) inhibition, Dihydrofolate Reductase In... |
|
2014
|
P/S
|
Pharmaceutical agents for lowering aldehyde levels by trapping aldehydes |
|
2013
|
P/S
|
Pharmaceutical preparations for treating disease, namely, inflammation, fibrosis, and excessive t... |
